VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 51 filers reported holding VERRICA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $532,191 | -31.9% | 136,986 | +1.2% | 0.03% | -28.3% |
Q2 2023 | $781,033 | -11.2% | 135,361 | 0.0% | 0.05% | -23.3% |
Q1 2023 | $879,847 | +134.6% | 135,361 | -0.7% | 0.06% | +114.3% |
Q4 2022 | $374,993 | -4.6% | 136,361 | +1.3% | 0.03% | -3.4% |
Q3 2022 | $393,000 | +51.7% | 134,661 | 0.0% | 0.03% | +52.6% |
Q2 2022 | $259,000 | -76.1% | 134,661 | +0.9% | 0.02% | -68.9% |
Q1 2022 | $1,082,000 | -11.3% | 133,411 | +0.2% | 0.06% | -11.6% |
Q4 2021 | $1,220,000 | -26.7% | 133,211 | +0.0% | 0.07% | -37.3% |
Q3 2021 | $1,665,000 | +10.9% | 133,161 | +0.2% | 0.11% | +4.8% |
Q2 2021 | $1,502,000 | -25.4% | 132,961 | 0.0% | 0.10% | -34.0% |
Q1 2021 | $2,014,000 | +31.6% | 132,961 | 0.0% | 0.16% | +14.4% |
Q4 2020 | $1,530,000 | +48.7% | 132,961 | 0.0% | 0.14% | +26.4% |
Q3 2020 | $1,029,000 | -29.4% | 132,961 | +0.5% | 0.11% | -40.2% |
Q2 2020 | $1,457,000 | +0.7% | 132,361 | 0.0% | 0.18% | -19.7% |
Q1 2020 | $1,447,000 | -31.2% | 132,361 | 0.0% | 0.23% | -21.0% |
Q4 2019 | $2,103,000 | – | 132,361 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Altium Capital Management LP | 256,244 | $3,203,000 | 0.84% |
Perceptive Advisors | 3,610,412 | $45,130,000 | 0.66% |
Orbimed Advisors | 1,479,733 | $18,497,000 | 0.20% |
Fosun International Ltd | 282,408 | $3,530,000 | 0.18% |
KORNITZER CAPITAL MANAGEMENT INC /KS | 728,236 | $9,103,000 | 0.14% |
SteelPeak Wealth, LLC | 133,161 | $1,665,000 | 0.11% |
HighVista Strategies LLC | 10,944 | $137,000 | 0.09% |
Capital Investment Advisory Services, LLC | 15,125 | $189,000 | 0.02% |
MML INVESTORS SERVICES, LLC | 44,875 | $561,000 | 0.00% |
BECK MACK & OLIVER LLC | 10,000 | $125,000 | 0.00% |